Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shirya Rashid

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
World Journal of Cardiology|December 17, 2010
Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatinShirya Rashid
The Canadian Journal of Cardiology|March 10, 2007
Should cholesterol-lowering medications be available in Canada without a prescription?Shirya Rashid
Obesity (Silver Spring, Md.)|January 17, 2008
Effect of obesity on high-density lipoprotein metabolismShirya Rashid, Jacques Genest
Clinical Biochemistry|April 12, 2005
The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissuesShirya Rashid, Gary F Lewis
Expert Review of Cardiovascular Therapy|September 23, 2014
Alirocumab: PCSK9 inhibitor for LDL cholesterol reductionHagai Tavori, Michelle Melone, Shirya Rashid
Expert Review of Cardiovascular Therapy|October 19, 2013
PCSK9 and resistin at the crossroads of the atherogenic dyslipidemiaShirya Rashid, John J P Kastelein
Atherosclerosis|December 30, 2014
On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effectsHagai Tavori, Shirya Rashid, Sergio Fazio
Circulation Research|February 5, 2011
Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signalingJustina Costandi, Michelle Melone, Alex Zhao, et al.
Clinical Biochemistry|September 3, 2003
Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activityShirya Rashid, Takehiko Watanabe, Taro Sakaue, et al.
Journal of Diabetes and Its Complications|March 2, 2002
The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant statesShirya Rashid, Kristine D Uffelman, Gary F Lewis
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
World Journal of Cardiology|December 17, 2010
Key questions resulting from the JUPITER trial assessing cardiovascular disease intervention with rosuvastatinShirya Rashid
The Canadian Journal of Cardiology|March 10, 2007
Should cholesterol-lowering medications be available in Canada without a prescription?Shirya Rashid
Obesity (Silver Spring, Md.)|January 17, 2008
Effect of obesity on high-density lipoprotein metabolismShirya Rashid, Jacques Genest
Clinical Biochemistry|April 12, 2005
The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissuesShirya Rashid, Gary F Lewis
Expert Review of Cardiovascular Therapy|September 23, 2014
Alirocumab: PCSK9 inhibitor for LDL cholesterol reductionHagai Tavori, Michelle Melone, Shirya Rashid
Expert Review of Cardiovascular Therapy|October 19, 2013
PCSK9 and resistin at the crossroads of the atherogenic dyslipidemiaShirya Rashid, John J P Kastelein
Atherosclerosis|December 30, 2014
On the function and homeostasis of PCSK9: reciprocal interaction with LDLR and additional lipid effectsHagai Tavori, Shirya Rashid, Sergio Fazio
Circulation Research|February 5, 2011
Human resistin stimulates hepatic overproduction of atherogenic ApoB-containing lipoprotein particles by enhancing ApoB stability and impairing intracellular insulin signalingJustina Costandi, Michelle Melone, Alex Zhao, et al.
Clinical Biochemistry|September 3, 2003
Mechanisms of HDL lowering in insulin resistant, hypertriglyceridemic states: the combined effect of HDL triglyceride enrichment and elevated hepatic lipase activityShirya Rashid, Takehiko Watanabe, Taro Sakaue, et al.
Journal of Diabetes and Its Complications|March 2, 2002
The mechanism of HDL lowering in hypertriglyceridemic, insulin-resistant statesShirya Rashid, Kristine D Uffelman, Gary F Lewis
Pageof 3